Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9716 |
Ensitrelvir
S-217622 |
SARS-CoV | Microbiology/Virology |
Ensitrelvir (S-217622) 是首个口服有效的、非共价的、非肽的SARS-CoV-2 3CL 蛋白酶抑制剂,IC50为13 nM。 | |||
T40358 |
Ensitrelvir fumarate
S-217622 fumarate |
||
Ensitrelvir (S-217622) fumarate is a novel orally active inhibitor, targeting the SARS-CoV-2 3CL protease (IC50 = 13 nM). It demonstrates non-covalent and non-peptidic characteristics. This compound represents a pioneering advancement in the development of effective antiviral agents against the SARS-CoV-2 virus. |